This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
FDA.FDA Drug Safety Communication: Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs. Internet Document: 26 Apr 2012. Available from: URL: http://www.fda.gov
About this article
Cite this article
The US FDA is recommending against co-administration of boceprevir [Victrelis] and certain ritonavir-boosted HIV protease inhibitors.. React. Wkly. 1400, 2 (2012). https://doi.org/10.2165/00128415-201214000-00005
- Public Health
- Protease Inhibitor
- Health Professional
- Treatment Response